These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 20524812)
1. Incidence of hepatocellular carcinoma in a thalassemia unit. Fragatou S; Tsourveloudis I; Manesis G Hemoglobin; 2010 Jun; 34(3):221-6. PubMed ID: 20524812 [TBL] [Abstract][Full Text] [Related]
2. Incidence of hepatocellular carcinoma in patients with thalassemia who had hepatitis C. Ansari S; Azarkivan A; Halagi F Acta Med Iran; 2013 Jul; 51(6):404-7. PubMed ID: 23852846 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C in patients with β-thalassemia major. A single-centre experience. Triantos C; Kourakli A; Kalafateli M; Giannakopoulou D; Koukias N; Thomopoulos K; Lampropoulou P; Bartzavali C; Fragopanagou H; Kagadis GC; Christofidou M; Tsamandas A; Nikolopoulou V; Karakantza M; Labropoulou-Karatza C Ann Hematol; 2013 Jun; 92(6):739-46. PubMed ID: 23412560 [TBL] [Abstract][Full Text] [Related]
4. A prospective study of hepatocellular carcinoma incidence in thalassemia. Mancuso A; Sciarrino E; Renda MC; Maggio A Hemoglobin; 2006; 30(1):119-24. PubMed ID: 16540424 [TBL] [Abstract][Full Text] [Related]
5. Iron chelation therapy in hereditary hemochromatosis and thalassemia intermedia: regulatory and non regulatory mechanisms of increased iron absorption. Kontoghiorghes GJ; Spyrou A; Kolnagou A Hemoglobin; 2010 Jun; 34(3):251-64. PubMed ID: 20524815 [TBL] [Abstract][Full Text] [Related]
6. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma. Momosaki S; Nakashima Y; Kojiro M; Tabor E J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475 [TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250 [TBL] [Abstract][Full Text] [Related]
8. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Shindo M; Ken A; Okuno T Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234 [TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738 [TBL] [Abstract][Full Text] [Related]
10. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381 [TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507 [TBL] [Abstract][Full Text] [Related]
12. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690 [TBL] [Abstract][Full Text] [Related]
13. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044 [TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry. Borgna-Pignatti C; Garani MC; Forni GL; Cappellini MD; Cassinerio E; Fidone C; Spadola V; Maggio A; Restivo Pantalone G; Piga A; Longo F; Gamberini MR; Ricchi P; Costantini S; D'Ascola D; Cianciulli P; Lai ME; Carta MP; Ciancio A; Cavalli P; Putti MC; Barella S; Amendola G; Campisi S; Capra M; Caruso V; Colletta G; Volpato S Br J Haematol; 2014 Oct; 167(1):121-6. PubMed ID: 24992281 [TBL] [Abstract][Full Text] [Related]
15. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000 [TBL] [Abstract][Full Text] [Related]
16. Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus- and hepatitis C virus-associated cirrhosis. Sato A; Kato Y; Nakata K; Nakao K; Daikoku M; Ishii N; Matsumoto T; Iseki K; Mazume H; Nagataki S J Gastroenterol Hepatol; 1996 Oct; 11(10):944-8. PubMed ID: 8912132 [TBL] [Abstract][Full Text] [Related]
17. Analysis of factors affecting the appearance of hepatocellular carcinoma in patients with chronic hepatitis C. A long term follow-up study after histologic diagnosis. Aizawa Y; Shibamoto Y; Takagi I; Zeniya M; Toda G Cancer; 2000 Jul; 89(1):53-9. PubMed ID: 10897000 [TBL] [Abstract][Full Text] [Related]
18. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes. Tsega E; Nordenfelt E; Hansson BG; Mengesha B; Lindberg J Ethiop Med J; 1992 Apr; 30(2 Suppl):1-33. PubMed ID: 1319901 [TBL] [Abstract][Full Text] [Related]
19. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic]. Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638 [TBL] [Abstract][Full Text] [Related]
20. [Hepatocarcinoma in HCV compensated correlated liver cirrhosis: role of treatment with interferon]. Testino G Recenti Prog Med; 2002 May; 93(5):302-7. PubMed ID: 12050912 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]